Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Short Interest Down 65.0% in February

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) was the recipient of a large decrease in short interest in the month of February. As of February 27th, there was short interest totaling 5,366 shares, a decrease of 65.0% from the February 12th total of 15,313 shares. Currently, 0.1% of the shares of the company are sold short. Based on an average daily volume of 20,956 shares, the days-to-cover ratio is currently 0.3 days. Based on an average daily volume of 20,956 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.1% of the shares of the company are sold short.

Invesco Pharmaceuticals ETF Price Performance

Shares of Invesco Pharmaceuticals ETF stock opened at $106.08 on Wednesday. The firm has a market cap of $405.23 million, a PE ratio of 15.59 and a beta of 0.50. Invesco Pharmaceuticals ETF has a 1 year low of $72.25 and a 1 year high of $110.81. The stock has a fifty day moving average price of $106.78 and a 200-day moving average price of $101.17.

Institutional Trading of Invesco Pharmaceuticals ETF

A number of large investors have recently added to or reduced their stakes in the stock. Northwestern Mutual Wealth Management Co. raised its position in Invesco Pharmaceuticals ETF by 829.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 25,941 shares of the company’s stock worth $2,712,000 after acquiring an additional 23,150 shares during the period. Wells Fargo & Company MN boosted its stake in Invesco Pharmaceuticals ETF by 96.8% in the fourth quarter. Wells Fargo & Company MN now owns 37,772 shares of the company’s stock valued at $3,949,000 after acquiring an additional 18,576 shares during the last quarter. BNP Paribas Financial Markets bought a new position in shares of Invesco Pharmaceuticals ETF during the 2nd quarter valued at approximately $799,000. Ameriprise Financial Inc. grew its position in shares of Invesco Pharmaceuticals ETF by 214.4% during the 3rd quarter. Ameriprise Financial Inc. now owns 12,236 shares of the company’s stock valued at $1,114,000 after acquiring an additional 8,344 shares during the period. Finally, Gilpin Wealth Management LLC purchased a new stake in shares of Invesco Pharmaceuticals ETF during the 4th quarter worth approximately $735,000.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.